Biodesix, Inc. BDSX Impairment of intangible assets
Impairment of intangible assets at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s impairment of intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s impairment of intangible assets?
- Biodesix, Inc. (BDSX) reported impairment of intangible assets of $5K in Q1 2026.
- How has Biodesix, Inc.'s impairment of intangible assets changed year-over-year?
- Biodesix, Inc.'s impairment of intangible assets decreased by 93.2% year-over-year, from $73K to $5K.
- What does impairment of intangible assets mean?
- This metric reflects the non-cash charge recognized when the carrying value of finite-lived intangible assets exceeds their recoverable amount. It indicates a reduction in the expected future economic benefits of acquired assets such as patents, licenses, or customer relationships. A significant impairment charge often signals a reassessment of the strategic value or market viability of previously acquired intellectual property.